MAPK3 c.250C>A ;(p.R84S)

Variant ID: 16-30133248-G-T

NM_002746.2(MAPK3):c.250C>A;(p.R84S)

This variant was identified in 8 publications

View GRCh38 version.




Publications:


Condensed-phase signaling can expand kinase specificity and respond to macromolecular crowding.

Molecular Cell
Sang, Dajun D; Shu, Tong T; Pantoja, Christian F CF; Ibáñez de Opakua, Alain A; Zweckstetter, Markus M; Holt, Liam J LJ
Publication Date: 2022-10-06

Variant appearance in text: MAPK3: R84S
PubMed Link: 36108633
Variant Present in the following documents:
  • Main text
  • nihms-1838958.pdf
View BVdb publication page



Development of small molecule extracellular signal-regulated kinases (ERKs) inhibitors for cancer therapy.

Acta Pharmaceutica Sinica. B
Pan, Xiaoli X; Pei, Junping J; Wang, Aoxue A; Shuai, Wen W; Feng, Lu L; Bu, Faqian F; Zhu, Yumeng Y; Zhang, Lan L; Wang, Guan G; Ouyang, Liang L
Publication Date: 2022-05

Variant appearance in text: ERK1: R84S
PubMed Link: 35646548
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



TRIM15 and CYLD regulate ERK activation via lysine-63-linked polyubiquitination.

Nature Cell Biology
Zhu, Guixin G; Herlyn, Meenhard M; Yang, Xiaolu X
Publication Date: 2021-09

Variant appearance in text: ERK1: R84S
PubMed Link: 34497368
Variant Present in the following documents:
  • Main text
  • NIHMS1722171-supplement-Statistical_Source_Data_for_Fig__7.xlsx, sheet 5
  • nihms-1722171.pdf
View BVdb publication page



Monoubiquitination of p120-catenin is essential for TGFβ-induced epithelial-mesenchymal transition and tumor metastasis.

Science Advances
Wu, Qingang Q; Li, Gao G; Wen, Chengwen C; Zeng, Taoling T; Fan, Yuxi Y; Liu, Chunyan C; Fu, Guo-Feng GF; Xie, Changchuan C; Lin, Qi Q; Xie, Liping L; Huang, Lei L; Pu, Pengpeng P; Ouyang, Zhong Z; Chan, Hong-Lin HL; Zhao, Tong-Jin TJ; Chen, Xiao Lei XL; Fu, Guo G; Wang, Hong-Rui HR
Publication Date: 2020-01

Variant appearance in text: ERK1: R84S
PubMed Link: 32010791
Variant Present in the following documents:
  • Main text
View BVdb publication page



Mutations That Confer Drug-Resistance, Oncogenicity and Intrinsic Activity on the ERK MAP Kinases-Current State of the Art.

Cells
Smorodinsky-Atias, Karina K; Soudah, Nadine N; Engelberg, David D
Publication Date: 2020-01-06

Variant appearance in text: ERK1: R84S
PubMed Link: 31935908
Variant Present in the following documents:
  • Main text
  • cells-09-00129.pdf
View BVdb publication page



Variants of the yeast MAPK Mpk1 are fully functional independently of activation loop phosphorylation.

Molecular Biology Of The Cell
Goshen-Lago, Tal T; Goldberg-Carp, Anat A; Melamed, Dganit D; Darlyuk-Saadon, Ilona I; Bai, Chen C; Ahn, Natalie G NG; Admon, Arie A; Engelberg, David D
Publication Date: 2016-09-01

Variant appearance in text: ERK1: R84S
PubMed Link: 27413009
Variant Present in the following documents:
  • Main text
View BVdb publication page



Intrinsically active variants of Erk oncogenically transform cells and disclose unexpected autophosphorylation capability that is independent of TEY phosphorylation.

Molecular Biology Of The Cell
Smorodinsky-Atias, Karina K; Goshen-Lago, Tal T; Goldberg-Carp, Anat A; Melamed, Dganit D; Shir, Alexei A; Mooshayef, Navit N; Beenstock, Jonah J; Karamansha, Yael Y; Darlyuk-Saadon, Ilona I; Livnah, Oded O; Ahn, Natalie G NG; Admon, Arie A; Engelberg, David D
Publication Date: 2016-03-15

Variant appearance in text: ERK1: R84S
PubMed Link: 26658610
Variant Present in the following documents:
  • Main text
  • 1026.pdf
View BVdb publication page



Isolation of intrinsically active (MEK-independent) variants of the ERK family of mitogen-activated protein (MAP) kinases.

The Journal Of Biological Chemistry
Levin-Salomon, Vered V; Kogan, Konstantin K; Ahn, Natalie G NG; Livnah, Oded O; Engelberg, David D
Publication Date: 2008-12-12

Variant appearance in text: ERK1: R84S
PubMed Link: 18829462
Variant Present in the following documents:
  • Main text
View BVdb publication page